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Abstract
Background: The role of copper accumulation in the onset of hepatitis is still unclear. Therefore,
we investigated a spontaneous disease model of primary copper-toxicosis in Doberman pinschers
so to gain insights into the pathophysiology of copper toxicosis, namely on genes involved in copper
metabolism and reactive oxygen species (ROS) defences.
Results: We used quantitative real-time PCR to determine differentially expressed genes within a
target panel, investigating different groups ranging from copper-associated subclinical hepatitis
(CASH) to a clinical chronic hepatitis with high hepatic copper concentrations (Doberman
hepatitis, DH). Furthermore, a non-copper associated subclinical hepatitis group (N-CASH) with
normal hepatic copper concentrations was added as a control. Most mRNA levels of proteins
involved in copper binding, transport, and excretion were around control values in the N-CASH
a n d  C A S H  g r o u p .  I n  c o n t r a s t ,  m a n y  o f  t h e s e  (including ATP7A, ATP7B, ceruloplasmin, and
metallothionein) were significantly reduced in the DH group. Measurements on defences against
oxidative stress showed a decrease in gene-expression of superoxide dismutase 1 and catalase in
both groups with high copper. Moreover, the anti-oxidative glutathione molecule was clearly
reduced in the DH group.
Conclusion: In the DH group the expression of gene products involved in copper efflux was
significantly reduced, which might explain the high hepatic copper levels in this disease. ROS
defences were most likely impaired in the CASH and DH group. Overall, this study describes a new
variant of primary copper toxicosis and could provide a molecular basis for equating future
treatments in dog and in man.
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Background
Copper is an imperative molecule in life; in contradiction,
however, it is highly toxic [1]. Like zinc, iron, and sele-
nium, copper is an essential trace element in diets and is
required for the activity of a number of physiologically
important enzymes [2]. Cells have highly specialized and
complex systems for maintaining intracellular copper
concentrations [3]. If this balance is disturbed, excess cop-
per can induce oxidative stress that could lead to chronic
inflammation [4,5]. Copper induced hepatitis has been
described both in humans (Wilson's disease) as well as in
dogs. There are several non-human models of copper tox-
icosis models, such as the Long-Evans Cinnamon rats and
Bedlington terriers. Although the gene underlying Wil-
son's disease (ATP7B) is deficient in Long-Evans Cinna-
mon rats [6-9], in Bedlington terriers it has been excluded
as a candidate for copper toxicosis [10]. The recent discov-
ery of mutations in gene MURR1, responsible for copper
toxicosis in Bedlington terriers, has given rise to the dis-
covery of a new copper pathway [11]. Here, we describe in
Doberman pinschers a copper associated chronic hepati-
tis (also called Doberman hepatitis), characterized by
micro-nodular cirrhosis with elevated hepatic copper con-
centrations [12-15]. Doberman hepatitis accounts for 4 %
of all deaths in a Dutch population of 340 Dobermans
[16]. Until recently, the role of copper in the development
and progression of hepatitis in the Doberman pinscher
had been unclear. Recent studies using intravenous 64Cu
clearly show an impaired copper excretion in dogs with
hepatitis and elevated copper concentrations [17]. How-
ever, genes ATP7B and MURR1 have been excluded by us
as possible candidates by genotyping (data not shown).
Therefore, Doberman hepatitis can be seen as a separate
form of copper toxicosis and a possible model for other
types of copper toxicosis in humans, such as Indian child-
hood cirrhosis, non-Indian childhood cirrhosis, or idio-
pathic copper toxicosis.
Intracellular copper is always transiently associated with
small copper-binding proteins (Figure 1), denoted copper
chaperones, which distribute copper to specific intracellu-
lar destinations [18]. One of these copper chaperones is
the anti-oxidant protein 1 (ATOX1) [19], which trans-
ports copper to the copper-transporting ATPases ATP7A
and ATP7B [20], located in the trans-Golgi network. Cop-
per can then be bound to liver specific ceruloplasmin
(CP) [21] or MURR1 and transferred outside the cell to
blood and bile, respectively [22]. The second chaperone –
cytochrome c oxidase (COX17) is responsible for deliver-
ing copper to the mitochondria for incorporation into
cytochrome c oxidase [23]. The third chaperone – copper
chaperone for superoxide oxidase (CCS) is responsible for
the incorporation of copper into Cu/Zn superoxide dis-
mutase (SOD1) – one of the most important cytosolic
enzymes in the defence against oxidative stress [24,25].
Also known as ferroxidase or oxygen oxidoreductase, CP
is a plasma metalloprotein which is involved in peroxida-
tion of Fe(II)transferrin to Fe(III)transferrin and forms 90
to 95 % of plasma copper. CP is synthesized in hepato-
cytes and is secreted into the serum with copper incorpo-
rated during biosynthesis. Metallothionein 1A (MT1A) is
a small intracellular protein capable of chelating several
metal ions, including copper. It contains many cysteine
residues, which allow binding and storage of copper. Fur-
thermore, MT1A is inducible, at the transcriptional level,
by metals and a variety of stressors such as reactive oxygen
species (ROS), hypoxia, and UV radiation [26]. MT1A can
donate copper to other proteins, either following degrada-
tion in lysosomes or by exchange via glutathione (GSH)
complexation [27].
High hepatic levels of copper induce oxidative stress.
There are several important proteins and molecules
involved in the defence against oxidative stress. Most of
the anti-oxidants can be grouped into either enzymatic
defences or non-enzymatic defences [28]. The enzymatic
defence against oxidative stress consists of several proteins
that have tight regulations such as SOD1 and catalase
(CAT). Non-enzymatic defences against oxidative stress
consist of molecules such as α -tocopherol,  β -carotene,
ascorbate, and a ubiquitous low molecular thiol compo-
nent – the GSH [29]. The present study was undertaken to
investigate the effect of copper toxicosis on expression of
gene-products involved in copper metabolism and oxida-
tive stress in several gradations of hepatic copper toxicosis
in Doberman pinschers.
Results
To gain insight into the pathogenesis of copper toxicosis,
we first measured mRNA levels on several important cop-
per binding gene-products by means of quantitative real-
time PCR (Q-PCR). Because copper toxicity is often asso-
ciated with oxidative stress, we also measured several oxi-
dative stress related gene-products. To determine a
possible damaging effect of the oxidative stress, we inves-
tigated proteins involved in apoptosis and cell-prolifera-
tion.
Gene-expression measurements on copper metabolism 
related gene products
Several proteins in the Doberman hepatitis (DH) group
are reduced compared to healthy controls (Figure 2C). In
all groups the copper chaperone ATOX1 is not affected,
whereas COX17 is decreased three-fold in the DH group
and remains unchanged in the non-copper associated
subclinical hepatitis group (N-CASH, Figure 2A) and cop-
per associated subclinical hepatitis group (CASH, Figure
2B). In the DH group, the mRNA levels of both trans-
Golgi copper transporting proteins ATP7A and ATP7B are
decreased, three- and two-fold respectively. Interestingly,Comparative Hepatology 2005, 4:3 http://www.comparative-hepatology.com/content/4/1/3
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mRNA levels of ATP7A are decreased in the CASH group
as well (Figure 2B). In contrast, ATP7B is not affected in
the CASH group but is induced two-fold in the N-CASH
group. CP mRNA levels are normal except for the DH
group where it is decreased two-fold. The same observa-
tion was made with measurements on MT1A mRNA,
although this protein is decreased four-fold in the DH
group. The protein MURR1 (that transports copper from
hepatocytes into bile) is unaffected in the N-CASH group
but halved in the CASH and DH groups.
Gene expression measurements on oxidative stress 
markers
SOD1 and CAT are reduced 7- and 4-fold (respectively) in
the DH group when compared to healthy controls (Figure
3C). This reduction in mRNA levels can be seen in the
CASH group (Figure 3B), where SOD1 and CAT are
halved, but are not lowered significantly in the N-CASH
group (Figure 3A). One of the GSH synthesis enzymes –
the glutathione synthetase (GSS) is unaffected in the N-
CASH group but reduced 2 to 4-fold in the CASH and DH
group, respectively. The glutathione peroxidase (GPX1)
responsible for converting oxidized glutathione (GSSG)
into its reduced form (GSH) is induced slightly in mRNA
expression in the N-CASH group, and is doubled in the
Schematic overview of intra-cellular copper trafficking in hepatocytes Figure 1
Schematic overview of intra-cellular copper trafficking in hepatocytes. Copper uptake is mediated by the receptor 
CTR1. In the cell, copper can bind to copper chaperones such as CCS, COX17, and ATOX1 which in turn deploy to SOD1, 
the mitochondrial COX, and ATP7A/B, respectively. ATP7A can directly excrete copper or bind it to ceruloplasmin (CP). 
ATP7B can excrete copper through CP to blood or via MURR1 to bile. Furthermore, metallothioneins (MT) are present in the 
cytoplasm which can bind and sequester metals. [SCO are metallochaperone proteins with essential, but not yet fully under-
stood, roles in copper delivery to mitochondrial COX.]
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Quantitative Real-Time PCR of copper metabolism related genes Figure 2
Quantitative Real-Time PCR of copper metabolism related genes. mRNA levels of non-copper associated subclinical 
hepatitis (n = 6 dogs) is shown in (A). mRNA levels of copper associated subclinical hepatitis (n = 6 dogs) is shown in (B). 
mRNA levels of Doberman hepatitis (n = 6 dogs) is shown in (C). Data represent mean ± 2 SD.
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Quantitative Real-Time PCR of oxidative stress markers Figure 3
Quantitative Real-Time PCR of oxidative stress markers. mRNA levels of non-copper associated subclinical hepatitis 
(n = 6 dogs) is shown in (A). mRNA levels of copper associated subclinical hepatitis (n = 6 dogs) is shown in (B). mRNA levels 
of Doberman hepatitis (n = 6 dogs) is shown in (C). Data represent mean ± 2 SD.
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CASH and DH groups. The third copper chaperone CCS,
responsible for the transport of copper to SOD1, is inhib-
ited 8-fold in the DH group, 2-fold in the CASH group,
and remained unchanged in the N-CASH group.
Gene expression measurements on apoptosis and cell 
proliferation
We measured two anti-apoptotic gene products, viz. Bcl-2,
the frequently described anti-apoptotic protein, and a x-
linked inhibitor of apoptosis (XIAP) recently associated
with MURR1 [30]. Our apoptosis measurements on Bcl-2
showed no reduction in gene expression in the N-CASH
group (Figure 4A), but is inhibited 4-fold in the CASH and
DH groups (Figures 4B and 4C, respectively). XIAP is
halved in all groups. The most dramatic changes were
found in the mRNA levels of the cell-cycle inhibitor
p27KIP which is inhibited 24-fold in the DH group, 12-
fold in the CASH group, and 3-fold in the N-CASH group.
Western blots analysis on metallothionein proteins during 
copper toxicosis
Measurements on the mRNA levels of MT1A showed a
marked decrease in gene expression in the DH group. In
order to see whether this decrease was also occurring at
the protein level, Western blots were performed in order
to confirm decreased mRNA levels. Therefore, the total
amount of metallothionein was determined from Dober-
man pinschers with chronic hepatitis and high copper
(DH-group) levels compared to healthy Dobermans. Met-
allothionein was detected in both samples, where it was
present as a single band of 6 kDa (Figure 5). Interestingly,
the immunoreactive band shows no difference in concen-
tration between the two samples.
Total Glutathione measurements during copper toxicosis
In order to determine whether the decrease in mRNA lev-
els of GSS decreases the GSH levels, we measured the total
amount of GSH. Interestingly, in Figure 6, the total
amount of GSH in the high copper group is halved when
compared to healthy controls.
Discussion
In the present study, the expression of a total of 15 gene
products involved in copper metabolism of Doberman
pinschers was measured. This provided insight into the
molecular pathways of a canine copper-associated hepatic
disease model ranging from subclinical hepatitis with ele-
vated copper levels (CASH) to severe chronic hepatitis
with high hepatic copper levels (DH). Furthermore, these
diseases were compared to non-copper associated subclin-
ical hepatitis (N-CASH).
Because of the centrolobular accumulation of copper in
the hepatocytes during copper toxicosis in the Doberman,
a probable defect may be sought in the copper metabo-
lism instead of a secondary effect due to, for instance,
cholestasis. Recent findings by Mandigers et al. [17] indi-
cated that Doberman pinschers with hepatitis and ele-
vated copper concentrations suffer from impaired 64Cu
bile excretion which is, together with other studies, con-
clusive that copper toxicosis exists in the Doberman pin-
scher. Furthermore, a double blind placebo-controlled
study with the copper chelating agent, D-penicillamine,
on Doberman pinschers with CASH showed a marked
improvement of liver pathology [31]; currently, that agent
is the only treatment option.
If copper is sequestered, in time metallothioneins will
store the copper in lysosomes, as described by Klein et al.
[32]. They found that chronic copper toxicity in Long-
Evans Cinnamon rats involved the uptake of copper-
loaded metallothioneins into lysosomes, where it was
incompletely degraded and polymerized into an insolu-
ble material, which contained reactive copper. This cop-
per initiated a lysosomal lipid peroxidation, which led to
hepatocyte necrosis. Phagocytosis of this reactive copper
by Kupffer cells amplified the liver damage. Histological
examination of the DH (Figure 7) and CASH group sam-
ples revealed copper accumulation in hepatocytes and
copper-laden Kupffer cells similar to that described by
Klein et al. [32]; therefore, that can be denoted as bench-
marks of chronic exposure to copper.
In our study, the gene expression levels of several gene
products involved in copper metabolism seem to be
reduced in the DH and CASH groups when compared to
healthy controls. Short term studies on in vitro models all
show an induction of MT1A or CP indicative of a higher
efflux of copper from hepatocytes [33,34]. The reductions
that are seen in our results could therefore be ascribed to
the prolonged or chronic nature of copper accumulation
as dogs in the high copper or DH group present clinical
signs after 2 years. Therefore, our observations are not
directly comparable with the short-term induced copper
effects in vitro, but are clinically more relevant, showing
the effects of long-term copper accumulation in Dober-
man hepatitis. However, Western blot experiments on
metallothionein, which stores the copper in lysosomes,
did not show any reduction at the protein level. This
observation could be ascribed to the antibody that binds
all metallothioneins, including metallothionein 2
(MT2A), which also is present in the liver. It remains to be
proven if this effect is a compensation for the decrease of
MT1A.
In the earlier stages of copper accumulation, comparable
to the CASH group, higher amounts of copper can still be
excreted. Interestingly, in the N-CASH group, ATP7B is
indeed induced compared to healthy controls, emphasiz-
ing a possible higher efflux of copper. Furthermore, fromComparative Hepatology 2005, 4:3 http://www.comparative-hepatology.com/content/4/1/3
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Quantitative Real-Time PCR of apoptosis and cell proliferation related genes Figure 4
Quantitative Real-Time PCR of apoptosis and cell proliferation related genes. mRNA levels of non-copper associ-
ated subclinical hepatitis (n = 6 dogs) is shown in (A). mRNA levels of copper associated subclinical hepatitis (n = 6 dogs) is 
shown in (B). mRNA levels of Doberman hepatitis (n = 6 dogs) is shown in (C). Data represent mean ± 2 SD.
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the two subclinical disease groups, the N-CASH group is
the only one able to recuperate, whereas the CASH group
will eventually turn into clinical hepatitis as seen in the
DH group (data not shown). Taken together, our data sug-
gest that in the Doberman pinchers copper accumulates in
time and, finally, will have its negative effect on copper
metabolism and induce oxidative stress.
Oxidative stress has been ascribed to copper toxicosis as
one of the most important negative effects [35]. We can
confirm this with four different observations: (i) our
measurements showed a decrease in mRNA levels of
SOD1 and CAT, indicative of a reduction in the enzymatic
defence against oxidative stress in all groups with copper
accumulation; (ii) a reduction of GSS mRNA levels
Western blot analysis of the metallothionein proteins Figure 5
Western blot analysis of the metallothionein proteins. Immunoreactive bands of total metallothionein of pooled frac-
tions of the Doberman hepatitis (DH) group (n = 6 dogs) versus healthy controls (n = 8 dogs).
Total glutathione (GSH) measurements during copper toxicosis in Doberman Figure 6
Total glutathione (GSH) measurements during copper toxicosis in Doberman. Total GSH levels of pooled protein 
fractions of the Doberman hepatitis (DH) group (n = 6 dogs) versus healthy controls (n = 8 dogs). Data represent mean ± 2 SD.
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(glutathione synthesis), indicative for a reduced
glutathione level in these groups which is one of the most
important non-enzymatic molecules against oxidative
stress; (iii) the mRNA levels of GPX1 were significantly
increased, indicating an increase in GSH oxidation; (iv)
the decrease in GSH was confirmed by measuring total
glutathione levels in the DH group towards healthy
Doberman pinschers. A similar decrease in expression of
anti-oxidant enzymes was observed in ApoE-deficient
mice in response to chronic inflammation [36], and
inflammatory bowel disease (IBD) [37]. This indicates
that chronic inflammation (copper toxicosis, atheroscle-
rosis, IBD) is associated with reduced protection against
enhanced exposure to ROS.
Other effects of high copper can also be seen in the meas-
urements on apoptosis and cell-cycle. Measurements on
Bcl-2 and XIAP indicate a decrease of protection against
apoptosis; however, the most affected hepatocytes will go
into necrosis due to the formation of hydroxyl radicals by
the Haber-Weiss reaction, which is catalyzed by copper
[38]. A striking observation was made measuring p27KIP
which was shown to be reduced up to 24-fold in the DH
group. This could indicate an induction of cell-cycle com-
pared to healthy controls. This could be ascribed to the
renewal of hepatocytes, thus managing the total amount
of copper in time.
Whether differential gene expression is cause-or-conse-
quence of hepatitis is unknown. However, it is
conceivable that the reduction in copper processing gene
products might explain copper accumulation and the sub-
sequent oxidative stress. Furthermore, recent Q-PCR
measurements on non-copper related hepatitis and extra
hepatic cholestasis suggest that ATP7A and CP are not
down-regulated by inflammation or cholestasis (data not
shown). Therefore, we can conclude that the decreased
expression of these gene products is a Doberman hepatitis
specific effect. Other important copper associated gene
products such as COX17, ATP7B, and MT1A are probably
down-regulated due to inflammation.
Conclusion
This study is the first to show the effect of prolonged expo-
sure to different copper levels on oxidative stress and cop-
per metabolism in canine livers. Our data supports that:
(i) Doberman hepatitis is a new variant of primary copper
toxicosis; (ii) there is a clear indication of a reduced cop-
per excretion in the Doberman hepatitis group; (iii) there
is a clear correlation between high copper levels and
reduced protection against ROS; (iv) this Doberman hep-
atitis could be a good model to study copper toxicosis and
its effects for several human copper storage diseases such
as Indian childhood cirrhosis, non-Indian childhood cir-
rhosis, and idiopathic copper toxicosis, and provide the
Histological evaluation of Doberman hepatitis Figure 7
Histological evaluation of Doberman hepatitis. (A) Hepatitis characterised by accumulation of pigmented granules 
(probably copper) in hepatocytes, and inflammation with lymphocytes and pigmented (probably copper) macrophages. HE 
staining. (B) Centrolobular accumulation of copper in hepatocytes and band of fibrous tissue with inflammatory cells and cop-
per-laden macrophages. Rubeanic acid staining. P = Portal area, CV = Central vein area.
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basis for possible future treatments in dog and even in
man.
Methods
Dogs
Doberman pinschers were kept privately as companion
animals. The dogs were presented to the Department of
Clinical Sciences of Companion Animals, Utrecht Univer-
sity, either for a survey investigating the prevalence of
Doberman (chronic) hepatitis, as described by Mandigers
et al. [39] or were referred for spontaneously occurring
liver disease. All samples were obtained after written con-
sent of the owner. The procedures were approved by the
Ethical Committee, as required under Dutch legislation.
Groups
Animals were divided in groups based on histopathologi-
cal examination and quantitative copper analysis. Each
group contained both sexes from four to seven years of
age. [A possible gender effect was later excluded by look-
ing at the individual data.] Liver tissue of all Doberman
pinschers was obtained using the Menghini aspiration
technique [40]. Four biopsies, 2–3 cm in length, were
taken with a 14-gauge Menghini needle for
histopathological examination and quantitative copper
analysis and stored for future quantitative PCR and pro-
tein investigations. The quantitative copper analysis was
performed using instrumental neutron activation analysis
via the determination of 64Cu [41]. Histopathological
biopsies were fixed in 10% neutral buffered formalin, rou-
tinely dehydrated and embedded in paraffin. Sections (4
µm thick) were stained with haematoxylin-eosin, van Gie-
son's stain, reticulin stain (according to Gordon and
Sweet), and with rubeanic acid. One experienced board
certified veterinary pathologist performed all histological
examinations. All diseased groups contained at least six
animals that were compared with a group of eight age-
matched healthy dogs. Four groups were included in this
study (Table 1):
1) Healthy group (n = 8 dogs), clinically healthy dogs
with normal liver enzymes and bile acids. Histopathology
of the liver did not reveal histomorphological lesions.
Liver copper concentrations were below 200 mg/kg dry
matter.
2) Non-copper associated subclinical hepatitis group (N-
CASH, n = 6 dogs), dogs with liver enzymes and bile acids
within reference values. Although histological examina-
tion showed evidence of a slight hepatitis, hepatic copper
concentrations were within normal levels, i.e., below 300
mg/kg dry matter. The dogs were classified as suffering
from subclinical hepatitis, which most likely was the
result of a different etiological factor, such as infections,
deficiencies, other toxins, deficient immune status or
immune-mediated mechanism [42].
3) Copper associated subclinical hepatitis group (CASH, n
= 6 dogs), dogs with liver enzymes and bile acids within
reference values. At histopathology these dogs showed
centrolobular copper-laden hepatocytes, on occasions
apoptotic hepatocytes associated with copper-laden
Kupffer cells, lymphocytes, plasma cells and scattered
neutrophils. These lesions were classified as subclinical
copper-associated hepatitis [43,44]. Hepatic copper con-
centrations were in all dogs above 600 mg/kg dry matter.
4) Doberman hepatitis group (DH, n = 6 dogs), dogs with
chronic hepatitis and elevated hepatic copper concentra-
tions. All dogs were referred with a clinical presentation of
hepatic failure (apathy, anorexia, vomiting, jaundice, and
in chronic cases sometimes ascites) and died within 2
months after diagnosis from this disease. Heparinized
plasma liver enzymes (alkaline phosphatase and alanine
aminotransferase) and fasting bile acids were, at least,
three times elevated above normal reference values.
Abdominal ultrasound revealed small irregular shaped
echo dense liver, as performed with a high definition
Ultrasound system – HDI 3000 ATL (Philips) – with a 4–
7 MHz broad band Faced-array transducer. Histopathol-
ogy showed chronic hepatitis (Figure 7A) with histologi-
cal features of fibrosis / micronodular cirrhosis, etc. These
lesions are comparable to chronic hepatitis in man [42].
Rubeanic acid staining revealed copper accumulation in
hepatocytes and Kupffer cells / macrophages (Figure 7B).
Table 1: Doberman pinscher group description
Group n Hepatic copper Copper concentrations 
(mg/kg dry matter)
Clinical observation
Healthy 8 Normal 100 – 200 No abnormalities
N-CASH 6 Normal < 300 Subclinical hepatitis
CASH 6 Elevated copper levels > 600 Subclinical hepatitis
DH 6 Highly elevated copper 
levels
> 1500 Chronic hepatitisComparative Hepatology 2005, 4:3 http://www.comparative-hepatology.com/content/4/1/3
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Hepatic copper concentrations were in all cases above
1500 mg/kg dry matter.
RNA isolation and reverse-transcription polymerase chain 
reaction
Total cellular RNA was isolated from each frozen Dober-
man liver tissue in duplicate, using Qiagen RNeasy Mini
Kit (Qiagen, Leusden, The Netherlands) according to the
manufacturer's instructions. The RNA samples were
treated with Dnase-I (Qiagen Rnase-free DNase kit). In
total 3 µg of RNA was incubated with poly(dT) primers at
42°C for 45 min, in a 60 µl reaction volume, using the
Reverse Transcription System from Promega (Promega
Benelux, Leiden, The Netherlands).
Q-PCR of oxidative-stress proteins, copper metabolism 
and other related signaling molecules
Q-PCR was performed on a total of 17 genes involved in
oxidative stress and copper metabolism. Real-time PCR
was based on the high affinity double-stranded DNA-
binding dye SYBR green I (SYBR® green I, BMA, Rockland,
ME) and was performed in triplicate in a spectrofluoro-
metric thermal cycler (iCycler®, BioRad, Veenendaal, The
Netherlands). For each PCR reaction, 1.67 µl (of the 2×
diluted stock) of cDNA was used in a reaction volume of
50 µl containing 1× manufacturer's buffer, 2 mM MgCl2,
0.5 × SYBR® green I, 200 µM dNTP's, 20 pmol of both
primers, 1.25 units of AmpliTaq Gold (Applied Biosys-
tems, Nieuwerkerk a/d IJssel, the Netherlands), on 96-
well iCycler iQ plates (BioRad). Primer pairs, depicted in
Table 2, were designed using PrimerSelect software
(DNASTAR Inc., Madison, WI). All PCR protocols
included a 5-minute polymerase activation step and con-
tinued with for 40 cycles (denaturation) at 95°C for 20
sec, annealing for 30 sec, and elongation at 72°C for 30
sec with a final extension for 5 min at 72°C. Annealing
temperatures were optimized at various levels ranging
from 50°C till 67°C (Table 2). Melt curves (iCycler, Bio-
Rad), agarose gel electrophoresis, and standard sequenc-
ing procedures were used to examine each sample for
purity and specificity (ABI PRISM 3100 Genetic Analyser,
Applied Biosystems). Standard curves constructed by plot-
ting the relative starting amount versus threshold cycles
were generated using serial 4-fold dilutions of pooled
cDNA fractions from both healthy and diseased liver tis-
sues. The amplification efficiency, E (%) = (10(1/-s)-1)·100
(s = slope), of each standard curve was determined and
appeared to be > 95 %, and < 105 %, over a wide dynamic
range. For each experimental sample the amount of the
gene of interest, and of the endogenous references glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) and
hypoxanthine phosphoribosyl transferase (HPRT) were
determined from the appropriate standard curve in auton-
omous experiments. If relative amounts of GAPDH and
HPRT were constant for a sample, data were considered
valid and the average amount was included in the study
(data not shown). Results were normalized according to
the average amount of the endogenous references. The
normalized values were divided by the normalized values
of the calibrator (healthy group) to generate relative
expression levels.
Western blot analysis
Pooled liver tissues (n = 6 dogs) were homogenized in
RIPA buffer containing 1 % Igepal, 0.6 mM
Phenylmethylsulfonyl fluoride, 17 µg/ml aprotinine and
1 mM sodium orthovanadate (Sigma chemical Co., Zwi-
jndrecht, The Netherlands). Protein concentrations were
obtained using a Lowry-based assay (DC Protein Assay,
BioRad). Thirty five µg of protein of the supernatant was
denatured in Leammli-buffer supplemented with Dithio-
threitol (Sigma Chemical Co.) for 3 min at 95°C and
electrophoresed on 10 % Tris-HCl SDS PAGE polyacryla-
mide gels (BioRad). Proteins were transferred onto
Hybond-C Extra Nitrocellulose membranes (Amersham
Biosciences Europe, Roosendaal, The Netherlands) using
a Mini Trans-Blot® Cell blot-apparatus (BioRad). The pro-
cedure for immunodetection was based on an ECL west-
ern blot analysis system, performed according to the
manufacturer's instructions (Amersham Biosciences
Europe). The membranes were incubated with 4 % ECL
blocking solution and 0.1 % Tween 20 (Boom B.V., Mep-
pel, The Netherlands) in TBS for 1 hour under gentle shak-
ing. The incubation of the primary antibody was
performed at room temperature for one hour, with a
1:2000 dilution of mouse anti-horse metallothionein
(DakoCytomation B.V., Heverlee, Belgium). After wash-
ing, the membranes were incubated with horseradish per-
oxidase-conjugated chicken anti-mouse (Westburg B.V.,
Leusden, The Netherlands) at room temperature for one
hour. Exposures were made with Kodak BioMax Light-1
films (Sigma chemical Co.).
Total GSH assay
The total amount of GSH was determined by a modified
version of a total GSH Determination Colorimetric Micro-
plate Assay according to Allen et al. [45], based on the
original Tietze macro assay [46]. Protein samples from
Doberman hepatitis (n = 6 dogs) and healthy controls (n
= 8 dogs) were isolated as described in Western blot anal-
ysis and subsequently pooled. Total protein concentration
was measured using a Lowry-based assay (DC Protein
Assay, BioRad). In short, 50 µl of the cell-lysate (1 mg/ml)
was used in triplicate in a 96-wells plate. The lysates were
incubated for 5 minutes with 50 µl of 1.3 mM
5,5'dithiobis-2-nitrobenzoic acid (DTNB), and 50 µl GSH
reductase (1.5 U/ml). To start the reaction 50 µl of
NADPH (0.7 mM) was added to the wells. Absorbance at
450 nm was measured at start and after 5 minutes. The
rate of 2-nitro-5-thiobenzoic acid production (yellowComparative Hepatology 2005, 4:3 http://www.comparative-hepatology.com/content/4/1/3
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product) was measured in delta absorbance per minute
and is directly proportionate with the amount of GSH in
the samples. A standard curve was added with known con-
centrations GSH (0 to 20 µM) in order to determine the
GSH concentrations in the samples.
Statistical analysis
A Kolmogorov-Smirnov test was performed to confirm
normal distribution of every group, and a Levene's test
checked the homogeneity of variances across groups. After
both verifications, the statistical significance of the
difference between the control group and each particular
non-healthy group was determined by using the Student's
t-Test. The significance level (α ) was set at 0.05.
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